152
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene® Study

ORCID Icon, , , ORCID Icon, , , ORCID Icon, , , ORCID Icon, , , , ORCID Icon & show all
Pages 1171-1181 | Published online: 27 Oct 2020

References

  • U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
  • Centers for Disease Control and Prevention. QuickStats: number of deaths from 10 leading causes—national vital statistics system, United States, 2010. Morbid Mortal Wkly Rep. 2013;62(08):155.
  • Kinney GL, Baker EH, Klein OL, et al. Pulmonary predictors of incident diabetes in smokers. Chronic Obstr Pulm Dis. 2016;3(4):739–747. doi:10.15326/jcopdf.3.4.2016.013727795984
  • Putcha N, Puhan MA, Drummond MB, et al. A simplified score to quantify comorbidity in COPD. PLoS One. 2014;9(12):e114438. doi:10.1371/journal.pone.011443825514500
  • Bang JH, Hwang SH, Lee EJ, Kim Y. The predictability of claim-data-based comorbidity-adjusted models could be improved by using medication data. BMC Med Inform Decis Mak. 2013;13:128. doi:10.1186/1472-6947-13-12824257030
  • Hagenaars MA. Applied Latent Class Analysis. Cambridge University Press: New York; 2009.
  • Pickles A, Bolton P, Macdonald H, et al. Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Am J Hum Genet. 1995;57(3):717–726.7668301
  • Islam MM, Valderas JM, Yen L, Dawda P, Jowsey T, McRae IS. Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns. PLoS One. 2014;9(1):e83783. doi:10.1371/journal.pone.008378324421905
  • Schüz B, Wurm S, Warner LM, Tesch-Römer C. Health and subjective well-being in later adulthood: different health states—different needs? Appl Psychol Health Well Being. 2009;1(1):23–45. doi:10.1111/j.1745-7254.2007.00657.x-i1
  • Pugh MJ, Finley EP, Copeland LA, et al. Complex comorbidity clusters in OEF/ OIF veterans: the polytrauma clinical triad and beyond. Med Care. 2014;52(2):172–181. doi:10.1097/mlr.000000000000005924374417
  • Kuwornu JP, Lix LM, Shooshtari S. Multimorbidity disease clusters in Aboriginal and non-Aboriginal Caucasian populations in Canada. Chronic Dis Inj Can. 2014;34(4):218–225.25408181
  • Swartz JA. Chronic medical conditions among jail detainees in residential psychiatric treatment: a latent class analysis. J Urban Health. 2011;88(4):700–717. doi:10.1007/s11524-011-9554-921394659
  • Larsen FB, Pedersen MH, Friis K, Glümer C, Lasgaard M. A latent class analysis of multimorbidity and the relationship to socio-demographic factors and health-related quality of life. A national population-based study of 162,283 Danish adults. PLoS One. 2017;12(1):e0169426. doi:10.1371/journal.pone.016942628056050
  • Kinney GL, Santorico SA, Young KA, et al. Identification of chronic obstructive pulmonary disease axes that predict all-cause mortality: the COPDGene study. Am J Epidemiol. 2018;187(10):2109–2116. doi:10.1093/aje/kwy08729771274
  • Young KA, Regan EA, Han MK, et al. Subtypes of COPD have unique distributions and differential risk of mortality. Chronic Obstr Pulm Dis. 2019;6(5):400–413. doi:10.15326/jcopdf.6.5.2019.015031710795
  • Young KA, Strand M, Ragland MF, et al. Pulmonary subtypes exhibit differential global initiative for chronic obstructive lung disease spirometry stage progression: the COPDGene® study. Chronic Obstr Pulm Dis. 2019;6(5):414–429. doi:10.15326/jcopdf.6.5.2019.015531710796
  • American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S73–s85. doi:10.2337/dc18-S008.29222379
  • American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–s28. doi:10.2337/dc19-S002.30559228
  • Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115.29133356
  • Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med. 2012;367(10):913–921. doi:10.1056/NEJMoa120383022938715
  • Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.13211595997
  • Lanza ST, Collins LM, Lemmon DR, Schafer JL. PROC LCA: a SAS procedure for latent class analysis. Struct Equ Modeling. 2007;14(4):671–694. doi:10.1080/1070551070157560219953201
  • Lo Y, Mendell N, Rubin D. Testing the number of components in a normal mixture. Biometrika. 2001;88(3):767–778. doi:10.1093/biomet/88.3.767
  • Masyn KE. Latent class analysis and finite mixture modeling In: Little TD, editor. The Oxford Handbook of Quantitative Methods in Psychology. New York: Oxford University Press; 2013:551–611.
  • Celeux G, Soromenho G. An entropy criterion for assessing the number of clusters in a mixture model. J Classif. 1996;13(2):195–212. doi:10.1007/BF01246098
  • Linda M, Collins STL. Latent Class and Latent Transition Analysis with Applications in the Social, Behavioral, and Health Sciences. Hoboken, NJ: John Wiley & Sons, Inc; 2010.
  • Liu Y, Elliott AL, Serdarevic M, Leeman RF, Cottler LB. A latent class analysis of the past-30-day substance use patterns among lifetime cocaine users: findings from a community sample in North Central Florida. Addict Behav Rep. 2019;9:100170. doi:10.1016/j.abrep.2019.10017031193730
  • Vatcheva KP, Lee M, McCormick JB, Rahbar MH. Multicollinearity in regression analyses conducted in epidemiologic studies. Epidemiology (Sunnyvale). 2016;6(2). doi:10.4172/2161-1165.1000227
  • Yoo W, Mayberry R, Bae S, Singh K, Peter HQ, Lillard JW. A study of effects of multicollinearity in the multivariable analysis. Int J Appl Sci Technol. 2014;4(5):9–19.25664257
  • Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: national heart, lung, and blood institute and World Health Organization global initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care. 2001;46(8):798–825.11463370
  • Wan ES, Hokanson JE, Murphy JR, et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med. 2011;184(1):57–63. doi:10.1164/rccm.201101-0021OC21493737
  • Wan ES, Castaldi PJ, Cho MH, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15(1):89. doi:10.1186/s12931-014-0089-y25096860
  • Reynolds GL, Fisher DG. A latent class analysis of alcohol and drug use immediately before or during sex among women. Am J Drug Alcohol Abuse. 2019;45(2):179–188. doi:10.1080/00952990.2018.152826630359095
  • Woodman RJ, Wood KM, Kunnel A, et al. Patterns of drug use and serum sodium concentrations in older hospitalized patients: a latent class analysis approach. Drugs Real World Outcomes. 2016;3(4):383–391. doi:10.1007/s40801-016-0094-127787771
  • Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. doi:10.1183/09031936.0001240818579551
  • André S, Conde B, Fragoso E, Boléo-Tomé JP, Areias V, Cardoso J. COPD and cardiovascular disease. Pulmonology. 2019;25(3):168–176. doi:10.1016/j.pulmoe.2018.09.00630527374
  • Underner M, Cuvelier A, Peiffer G, Perriot J, Jaafari N. [The influence of anxiety and depression on COPD exacerbations]. Rev Mal Respir. 2018;35(6):604–625. French. doi:10.1016/j.rmr.2018.04.00429937312
  • Lim JU, Park CK, Kim TH, et al. The difficulty of improving quality of life in COPD patients with depression and associated factors. Int J Chron Obstruct Pulmon Dis. 2019;14:2331–2341. doi:10.2147/copd.S21674631632002
  • Vozoris NT, Wang X, Austin PC, et al. Serotonergic antidepressant use and morbidity and mortality among older adults with COPD. Eur Respir J. 2018;52(1):1800475. doi:10.1183/13993003.00475-201829946006
  • Xie X, Liu Y, Perkovic V, et al. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian Network meta-analysis of randomized clinical trials. Am J Kidney Dis. 2016;67(5):728–741. doi:10.1053/j.ajkd.2015.10.01126597926
  • WHO Guidelines Approved by the Guidelines Review Committee. Use of Glycated Haemoglobin (Hba1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva: World Health Organization Copyright © World Health Organization; 2011.
  • Paulin LM, Gassett AJ, Alexis NE, et al. Association of long-term ambient ozone exposure with respiratory morbidity in smokers. JAMA Intern Med. 2019. doi:10.1001/jamainternmed.2019.5498